Lucas E. Hermans

783 total citations
20 papers, 331 citations indexed

About

Lucas E. Hermans is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Lucas E. Hermans has authored 20 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 12 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Lucas E. Hermans's work include HIV/AIDS Research and Interventions (15 papers), HIV Research and Treatment (12 papers) and HIV/AIDS drug development and treatment (11 papers). Lucas E. Hermans is often cited by papers focused on HIV/AIDS Research and Interventions (15 papers), HIV Research and Treatment (12 papers) and HIV/AIDS drug development and treatment (11 papers). Lucas E. Hermans collaborates with scholars based in South Africa, Netherlands and United States. Lucas E. Hermans's co-authors include Annemarie M. J. Wensing, Hugo A. Tempelman, François Venter, Sergio Carmona, Diederick E. Grobbee, Douglas D. Richman, Michelle Moorhouse, L. Marije Hofstra, Monique Nijhuis and W.L.J.M. Devillé and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Lucas E. Hermans

17 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucas E. Hermans South Africa 8 290 226 86 40 25 20 331
Désiré Takou Cameroon 11 233 0.8× 152 0.7× 71 0.8× 21 0.5× 18 0.7× 39 294
Raffaella Bucciardini Italy 11 263 0.9× 171 0.8× 87 1.0× 98 2.5× 26 1.0× 27 318
Awachana Jiamsakul Australia 11 264 0.9× 149 0.7× 108 1.3× 54 1.4× 53 2.1× 25 318
Vincenzo Fragola Italy 11 269 0.9× 183 0.8× 85 1.0× 101 2.5× 20 0.8× 32 320
Anitha J. Cecelia India 9 262 0.9× 171 0.8× 87 1.0× 46 1.1× 27 1.1× 10 328
Selly Ba Senegal 11 169 0.6× 118 0.5× 65 0.8× 43 1.1× 38 1.5× 17 276
Sorakij Bhakeecheep Thailand 11 302 1.0× 210 0.9× 96 1.1× 93 2.3× 17 0.7× 19 352
Rose Mougnutou Cameroon 7 399 1.4× 313 1.4× 124 1.4× 38 0.9× 26 1.0× 8 470
Daniela Francisci Italy 11 161 0.6× 121 0.5× 82 1.0× 38 0.9× 28 1.1× 33 250
Thompson Kinge Cameroon 11 202 0.7× 178 0.8× 96 1.1× 18 0.5× 20 0.8× 23 302

Countries citing papers authored by Lucas E. Hermans

Since Specialization
Citations

This map shows the geographic impact of Lucas E. Hermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas E. Hermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas E. Hermans more than expected).

Fields of papers citing papers by Lucas E. Hermans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucas E. Hermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas E. Hermans. The network helps show where Lucas E. Hermans may publish in the future.

Co-authorship network of co-authors of Lucas E. Hermans

This figure shows the co-authorship network connecting the top 25 collaborators of Lucas E. Hermans. A scholar is included among the top collaborators of Lucas E. Hermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucas E. Hermans. Lucas E. Hermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Omar, Tanvier, Alistair Calver, Lucas E. Hermans, et al.. (2025). Causes of death in adults living with HIV in South Africa: A single-centre postmortem study. Southern African Journal of HIV Medicine. 26(1). 1673–1673.
2.
Hermans, Lucas E., Sean Wasserman, Lizhen Xu, & John W. Eikelboom. (2025). Long COVID prevalence and risk factors in adults residing in middle- and high-income countries: secondary analysis of the multinational Anti-Coronavirus Therapies (ACT) trials. BMJ Global Health. 10(4). e017126–e017126.
3.
Hermans, Lucas E., Neeltje A. Kootstra, Irma Maurer, et al.. (2024). Defective proviruses significantly impact viral transcription and immune activation in men and women with HIV-1 subtype C in rural South Africa. Frontiers in Immunology. 15. 1484358–1484358. 5 indexed citations
4.
Hermans, Lucas E., Chad M. Centner, Chantal Morel, et al.. (2023). Point-of-care diagnostics for infection and antimicrobial resistance in sub-Saharan Africa: A narrative review. International Journal of Infectious Diseases. 142. 106907–106907. 3 indexed citations
5.
Wensing, Annemarie M. J., Samanta Tresha Lalla‐Edward, John de Wit, et al.. (2023). Predictors of Treatment Adherence and Virological Failure Among People Living with HIV Receiving Antiretroviral Therapy in a South African Rural Community: A Sub-study of the ITREMA Randomised Clinical Trial. AIDS and Behavior. 27(12). 3863–3885. 4 indexed citations
6.
Tempelman, Hugo A., et al.. (2023). Prevalence, incidence and recurrence of sexually transmitted infections in HIV‐negative adult women in a rural South African setting. Tropical Medicine & International Health. 28(4). 335–342.
7.
Majam, Mohammed, et al.. (2023). Utility of a machine-guided tool for assessing risk behaviour associated with contracting HIV in three sites in South Africa. Informatics in Medicine Unlocked. 37. 101192–101192. 9 indexed citations
8.
Tempelman, Hugo A., Kerstin Klipstein‐Grobusch, Lucas E. Hermans, et al.. (2023). Unmasking a silent killer: Prevalence of diagnosed and undiagnosed diabetes mellitus among people living with HIV in rural South Africa. Tropical Medicine & International Health. 28(5). 367–373. 6 indexed citations
9.
Hermans, Lucas E., Rob ter Heine, Rob Schuurman, et al.. (2022). A randomized study of intensified antiretroviral treatment monitoring versus standard-of-care for prevention of drug resistance and antiretroviral treatment switch. AIDS. 36(14). 1959–1968. 1 indexed citations
10.
Hermans, Lucas E., Samanta Tresha Lalla‐Edward, Hugo A. Tempelman, et al.. (2022). Point-of-Care Tenofovir Urine Testing for the Prediction of Treatment Failure and Drug Resistance During Initial Treatment for Human Immunodeficiency Virus Type 1 (HIV-1) Infection. Clinical Infectious Diseases. 76(3). e553–e560. 13 indexed citations
11.
Lewis, Lara, Yukteshwar Sookrajh, Kelly Gate, et al.. (2021). Differentiated service delivery for people using second‐line antiretroviral therapy: clinical outcomes from a retrospective cohort study in KwaZulu‐Natal, South Africa. Journal of the International AIDS Society. 24(S6). e25802–e25802. 6 indexed citations
12.
Mbuagbaw, Lawrence, Babalwa Zani, Annie Wang, et al.. (2021). Guidelines are needed for studies of pre-treatment HIV drug resistance: a methodological study. BMC Medical Research Methodology. 21(1). 76–76. 5 indexed citations
13.
Hermans, Lucas E., Monique Nijhuis, Hugo A. Tempelman, et al.. (2021). Point-of-Care Detection of Nonadherence to Antiretroviral Treatment for HIV-1 in Resource-Limited Settings Using Drug Level Testing for Efavirenz, Lopinavir, and Dolutegravir: A Validation and Pharmacokinetic Simulation Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(4). 1072–1078. 3 indexed citations
14.
Hermans, Lucas E., Sergio Carmona, Monique Nijhuis, et al.. (2020). Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study. PLoS Medicine. 17(2). e1003037–e1003037. 36 indexed citations
15.
Connell, Bridgette J., Lucas E. Hermans, Annemarie M. J. Wensing, et al.. (2020). Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection. Scientific Reports. 10(1). 15866–15866. 24 indexed citations
16.
Hermans, Lucas E., et al.. (2020). Risk factors for loss to follow-up from antiretroviral therapy programmes in low-income and middle-income countries. AIDS. 34(9). 1261–1288. 39 indexed citations
17.
Hermans, Lucas E., Kim Steegen, Rob ter Heine, et al.. (2020). Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second‐line ART. Journal of the International AIDS Society. 23(6). e25501–e25501. 17 indexed citations
18.
Bertagnolio, Silvia, Lucas E. Hermans, Michael R. Jordan, et al.. (2020). Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor–Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis. The Journal of Infectious Diseases. 224(3). 377–388. 44 indexed citations
19.
Hermans, Lucas E., Michelle Moorhouse, Sergio Carmona, et al.. (2017). Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study. The Lancet Infectious Diseases. 18(2). 188–197. 112 indexed citations
20.
Hermans, Lucas E., et al.. (2012). Delayed HIV testing in internal medicine clinics - a missed opportunity.. PubMed. 70(2). 69–73. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026